Karyopharm Therapeutics (KPTI) to Update on Multiple Myeloma Trajectory; Plans Expansion of Selinexor Phase 2b
Go back to Karyopharm Therapeutics (KPTI) to Update on Multiple Myeloma Trajectory; Plans Expansion of Selinexor Phase 2bKARYOPHARM THERAP (NASDAQ: KPTI) | Delayed: 1.28 -0.1 (7.25%) | |||||
---|---|---|---|---|---|---|
Previous Close | $1.38 | 52 Week High | $19.41 | |||
Open | $1.42 | 52 Week Low | $4.83 | |||
Day High | $1.42 | P/E | N/A | |||
Day Low | $1.22 | EPS | $-2.74 | |||
Volume | 1,306,162 |